申请人:Wuxi Fortune Pharmaceutical Co., Ltd
公开号:EP3248980A1
公开(公告)日:2017-11-29
The present invention discloses a series of JAK inhibitors, and particularly discloses a compound of formula (I) or a pharmaceutically acceptable salt thereof and the use thereof in preparation of drugs for treating diseases related to JAK.
本发明公开了一系列 JAK 抑制剂,特别是公开了一种式(I)化合物或其药学上可接受的盐及其在制备治疗 JAK 相关疾病的药物中的用途。